# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(2.14) per share which beat the analyst consensus estimate of $(2.70) ...
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...